TESTRED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Testred, and when can generic versions of Testred launch?
Testred is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in TESTRED is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Testred
A generic version of TESTRED was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
Summary for TESTRED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 4,266 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TESTRED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TESTRED
US Patents and Regulatory Information for TESTRED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | TESTRED | methyltestosterone | CAPSULE;ORAL | 083976-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |